impact:

nektar.com

Nektar Therapeutics (Nektar) is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, etc. The company developed the world's first inhalable non-injectable insulin, Exubera, which was awarded as the bronze award by Wall Street Journal for its technological breakthrough. More information...

According to PR-model, nektar.com is ranked 864,778th in multilingual Wikipedia, in particular this website is ranked 516,126th in English Wikipedia.

The website is placed before p-z-nt.ru and after comitau.org in the BestRef global ranking of the most important sources of Wikipedia.

#Language
PR-model F-model AR-model
864,778th place
508,238th place
872,582nd place
516,126th place
384,955th place
618,254th place
deGerman
331,456th place
288,051st place
405,072nd place
249,345th place
269,700th place
143,683rd place
arArabic
211,095th place
191,732nd place
206,146th place
112,960th place
47,550th place
121,752nd place
koKorean
83,119th place
55,196th place
88,916th place